<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

REVIEW OF RARE DISEASE POLICY DEVELOPMENTS IN EUROPE AND TÜRKIYE 2020-2025 IN THE CONTEXT OF INNOVATIVE ORPHAN DRUGS

Simple item page
dc.contributor.authorSaylan, Mete
dc.contributor.authorSimsek, Ceren
dc.contributor.authorSeyhun, Oznur
dc.contributor.authorKockaya, Guvenc
dc.date.accessioned2026-11-05T11:02:44Z
dc.date.issued2025
dc.description.issue12
dc.description.volume28
dc.identifier.issn1098-3015
dc.identifier.issn1524-4733
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/10964
dc.identifier.wosWOS:001664219100047
dc.language.isoen
dc.publisherELSEVIER SCIENCE INC
dc.relation.ispartofVALUE IN HEALTH
dc.subjectEconomics
dc.subjectHealth Care Sciences & Services
dc.subjectHealth Policy & Services
dc.subjectBusiness & Economics
dc.titleREVIEW OF RARE DISEASE POLICY DEVELOPMENTS IN EUROPE AND TÜRKIYE 2020-2025 IN THE CONTEXT OF INNOVATIVE ORPHAN DRUGS
dc.typeMeeting Abstract
oaire.citation.editionScience Citation Index Expanded (SCI-EXPANDED)
oaire.citation.editionSocial Science Citation Index (SSCI)
oaire.citation.issue12
oaire.citation.volume28
person.identifier.ridB-5648-2008

Files

Collections

WOS